90 related articles for article (PubMed ID: 3066044)
1. [Therapy of heart failure with vasodilator agents].
Just H; Drexler H; Holubarsch C
Z Kardiol; 1988; 77 Suppl 5():97-101. PubMed ID: 3066044
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
Groden DL
Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
[TBL] [Abstract][Full Text] [Related]
3. [Peripheral adaptation in chronic heart failure: therapeutic implications].
Drexler H
Herz; 1991 Sep; 16 Spec No 1():334-9. PubMed ID: 1820301
[TBL] [Abstract][Full Text] [Related]
4. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
[TBL] [Abstract][Full Text] [Related]
5. Are alterations of skeletal muscle ultrastructure in patients with heart failure reversible under treatment with ACE-inhibitors?
Münzel T; Kurz S; Drexler H
Herz; 1993 Dec; 18 Suppl 1():400-5. PubMed ID: 8125419
[TBL] [Abstract][Full Text] [Related]
6. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
Chow MS
Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of heart failure: status of therapy with vasodilator agents].
Just H
Herz; 1987 Dec; 12 Suppl 1():22-6. PubMed ID: 3436615
[TBL] [Abstract][Full Text] [Related]
8. [The role of ACE inhibitors in heart failure. Lessons of CONSENSUS, SOLVD and V-HeFTII].
Dessì-Fulgheri P; Paci MV; Rappelli A
Ann Ital Med Int; 1994 Oct; 9 Suppl():16S-18S. PubMed ID: 7857751
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of angiotensin-converting enzyme inhibition in heart failure: expanding the protective envelope.
Teerlink JR
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S32-7. PubMed ID: 7700062
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
11. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
Abrams WB; Davies RO; Ferguson RK
Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
Sami M
Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
[TBL] [Abstract][Full Text] [Related]
13. [Vasodilator agents in chronic heart failure: which is the best option?].
Corbalán R; Kunstmann S; Jalil J
Rev Med Chil; 1993 Jan; 121(1):81-8. PubMed ID: 8235172
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology of heart failure: peripheral vascular and muscular mechanisms].
Kiowski W
Ther Umsch; 1993 Jun; 50(6):394-400. PubMed ID: 8351668
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of cardiac failure with angiotensin-converting enzyme inhibitors and diuretics].
Deray G; Martinez F; Jacobs C
Arch Mal Coeur Vaiss; 1996 Jun; 89(6):735-40. PubMed ID: 8760660
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
19. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
[TBL] [Abstract][Full Text] [Related]
20. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
